Survival enhancing indications for coronary artery bypass graft surgery in California

Zhongmin Li1, Richard L Kravitz, James P Marcin

  • 1Division of General Internal Medicine and Center for Healthcare Policy and Research, University of California, Davis, Sacramento, CA, USA. zmli@ucdavis.edu

Insights

California hospitals and surgeons show significant variation in clinical indications for coronary artery bypass graft (CABG) surgery. Patient characteristics, not hospital or surgeon factors, primarily explain these differences in CABG indications.

Area of Science:

  • Cardiovascular Surgery
  • Health Services Research
  • Surgical Outcomes

Background:

  • Coronary artery bypass graft (CABG) surgery aims to improve survival and quality of life.
  • Understanding variations in CABG indications is crucial for optimizing patient care.

Purpose of the Study:

  • To explore variations in clinical indications for CABG surgery among California hospitals and surgeons.
  • To identify factors associated with the use of survival-enhancing indications for CABG.

Main Methods:

  • Utilized California CABG Outcomes Reporting Program data from 2003-2004.
  • Classified isolated CABG cases into "probable survival enhancing indications (SEIs)", "possible SEIs", or "non-SEIs".
  • Examined patient and hospital characteristics linked to SEIs.

Main Results:

  • 82.9% of CABG procedures had probable SEIs, with significant hospital (68-96%) and surgeon (51-100%) level variations.
  • SEI rates were higher in older patients (>or= 65), Asian and Native American ethnicities, and those with comorbidities (hypertension, PVD, diabetes, CVD, CHF).
  • Variations in indications were more strongly associated with patient mix than hospital or surgeon effects (ICC=0.04 and 0.01, respectively).

Conclusions:

  • Observed variations in CABG indications among California hospitals and surgeons warrant further investigation.
  • Future research should explore market factors, referral patterns, patient preferences, and local clinical culture's role in these variations.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...